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1. Introduction 
Diagnostics have taken on a larger role in patient care, with diagnostics for point-of-care 
testing (POCT) having greatly expanded during the last two decades. The expectation is that 
POCT will continue to grow because it can help to expand personalized therapy and 
theranostics, which will provide the right medicine to the right person, with the right 
dosage at the right time. For POCT, it will be necessary to construct miniaturized biosensors 
at a low cost that have high sensitivity with rapid sensing.  
Affinity-based techniques that are used in clinical diagnostics rely on the high affinity and 
specificity of antibodies for highly sensitive detection of target molecules. Antibody-based 
diagnostic systems are well established, and enable the detection of various molecules. 
However, aptamers are expected to be the next-generation elements for molecular recognition. 
Aptamers are short strands of nucleic acids that have been designed to specifically bind to 
various target molecules, and have comparable affinity and specificity to antibodies. They 
are selected using the SELEX (Systematic Evolution of Ligands by Exponential Enrichment) 
technique (Tuerk & Gold, 1990), also referred to as "in vitro selection" or "in vitro evolution."  
SELEX is a combinatorial chemistry technique that produces single-stranded 
oligonucleotides of DNA or RNA, which specifically bind to a target ligand(s).  
It has been two decades since the first report on aptamers became public (Ellington & 
Szostak, 1990; Tuerk & Gold, 1990). During these two decades, many aptamers have been 
reported and an aptamer has been approved as a therapeutic medicine by the US Food and 
Drug Administration (FDA). Aptamers have many advantages as biosensors that antibodies 
do not have, such as:  
1. The ability to be selected by SELEX. 
2. The ability to be synthesized and modified. 
3. The ability to renature. 
4. More stability than antibodies. 
5. The ability to change conformation upon binding to target molecules.  
For theranostics, the first advantage is important when it is necessary to obtain affinity 
probes against various novel biomarkers. SELEX has many advantages, and is an excellent 
method to evolve aptamers so that they have an extremely high binding affinity to a variety 
of target ligands. We were able to successfully achieve the automatic in vitro screening of 
aptamers, which enabled us to obtain aptamers against more than 100 proteins per month 
(Cox & Ellington, 2001). Aptamers can therefore be developed more rapidly than antibodies. 
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In addition, since there is virtually no shortage of targets for aptamers, we can obtain 
aptamers against small molecules, peptides, proteins and even cells.  
Aptamers selected by SELEX against purified membrane proteins often do not bind to 
native membrane proteins on the cell because the membrane protein will change its 
conformation after purification. Since Cell-SELEX enables us to treat native membrane 
proteins as target molecules, we can obtain more useful aptamers for cell identification 
(Pestourie et al., 2006). SELEX against unpurified protein, including Cell-SELEX, can be 
utilized to identify biomarkers as well (Berezovski et al., 2008; Noma et al., 2006a). Although 
in vitro selection is a powerful method to obtain aptamers, selected aptamers often require 
optimization for the best affinity and specificity. We can perform post-optimization of their 
sequences after SELEX through iterative cycles of mutated DNA synthesis and evaluation of 
their functions, which would be a cumbersome process for antibodies (Ikebukuro et al., 
2005b; Ikebukuro et al., 2006; Knight et al., 2009; Noma & Ikebukuro, 2006; Noma et al., 
2006b; Savory et al., 2010).  
The fifth advantage is important so that aptamers can be perceived as unique reagents for 
analytical applications, not as alternatives to antibodies. Since aptamers are a kind of 
biopolymer consisting of nucleic acids that have many negative charges, their tertiary 
structures are destabilized by repulsion between phosphate backbones. In addition, since 
aptamers are formed by Watson-Crick base pairing, some aptamers have the ability to form 
different structures. Target molecule binding stabilizes a particular structure, even though 
the structure would have little chance of forming without the target molecules. Aptamers 
have the potential to change structures, and in some cases, drastically. Many aptameric 
sensors have been reported that rely on the transduction of structural changes into 
detectable signals (Han et al., 2010; Li et al., 2010).  
In this chapter, we focus on enzymes that are combined with aptamer sensors. Since 
enzymes catalyze various kinds of reactions, they are used as biosensors for many 
biomarkers. In addition, since catalytic turnover of enzymes enables signal amplification at 
moderate temperatures, it enables affinity-based biosensors to measure target molecules 
with high sensitivity, and without the need for radioisotopes. Most antibody-based 
diagnostics systems use enzyme-labeled antibodies. For the combination of aptamers with 
enzymes, aptamers would work not only as a replacement molecule for antibodies, but also 
as a part of a new device that can exploit the unique properties of aptamers. First, we 
categorize aptamer sensors based on how to combine enzymes with aptamer sensors. 
Second, we describe the detail of the enzymes and discuss them based on biosensors for 
highly sensitive detection and POCT. 
2. Strategy of enzyme combination with aptamer sensors 
The key point of combining an aptamer sensor with an enzyme is the ability to distinguish 
aptamer–target molecular complexes from unbound aptamers before signal amplification. 
Figure 1 shows how aptamer sensors using enzymes are divided into two groups based on 
how to distinguish aptamer-protein complexes from unbound aptamer. Bound free (B/F) 
separation can easily purify aptamer-protein complexes by eliminating unbound aptamer. 
Ordinarily, to eliminate unbound aptamer and detect an aptamer-protein complex by its 
enzyme activity, a sandwich assay is applied. Most clinical diagnostic methods use an 
antibody-based sandwich assay such as the enzyme-linked immunosorbent assay (ELISA). 
However, we constructed a biosensor using an aptamer which had the unique properties of 
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aptamers, as well as their ability to bind to the target molecule. When we perform B/F 
separation using an antibody, we apply a competitive assay. However, a competitive assay 
requires purified target molecules, and the process is difficult when the purification of a 
target molecule is laborious. As mentioned above, aptamers have unique features: their 
structural change is accompanied by target binding. Therefore, we can construct an aptamer 
based B/F separation system that is not a competitive assay. 
The second group does not require B/F separation, and regulates enzymatic activity by 
using target molecules. It can be divided into two subgroups. One group regulates 
enzymatic activity directly by using target molecules. The other group changes the input 
DNA structure into an output DNA structure that can serve as a substrate for polymerase. 
Since the polymerase can replicate the substrate DNA, we can control the polymerase 
reaction via regulation of the substrate DNA. 
We will describe the details of each group separately. 
 
 
Fig. 1. A schematic of the two categories of aptamer sensors that use enzymes. Aptamer 
sensors that use enzymes are divided into two main groups. The first group requires B/F 
separation, and the second group does not require it. The first group is divided into two 
subgroups based on how the B/F separation is performed. The second group is divided into 
two subgroups based on how enzymatic activity is regulated. In one subgroup, enzymatic 
activity is regulated directly by the activity of the aptamer, and in the other, the structure of 
the aptamer is regulated by target binding for DNA amplification. 
2.1 Sensing with bound free separation 
2.1.1 Sandwich assay 
B/F separation is an attractive process because it can eliminate not only unbound enzyme-
modified molecular recognition elements, but also nonspecific binding and some molecules 
that affect noise. Since B/F separation reduces background signal and noise, it enables 
highly sensitive detection. Most clinical diagnostic methods using antibodies are based on 
the sandwich strategy. A sandwich assay requires two molecular recognition elements that 
bind to the target molecule simultaneously. One is immobilized on a solid support such as 
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beads or plates, and the other one is modified with enzymes. Using them, unbound 
molecular recognition elements modified with enzymes can be removed, and the target 
molecule can be detected without the need to label target molecules via enzyme activity 
measurements (Fig. 2). There have been many reports that describe the sandwich assay (Han 
et al., 2010) and many types of enzymes have been mentioned in these reports, as we will 
discuss later. Sometimes, the aptamers modified with enzymes are used as detection 
reagents, and antibodies are used for capturing the target reagent. A chemical crosslink is 
required when antibodies are modified with enzymes, and it often causes a loss of function. 
However, since aptamers can be easily modified with various molecules, they can simply be 
connected with any enzyme via interaction with modified molecules and their partner 
molecules, such as biotin and avidin. 
 
 
Fig. 2. Sandwich assay using an aptamer. On the left side, the antibody is used as a capture 
reagent and the enzyme-modified aptamer is used as a detection reagent. On the right side, 
different aptamers are used as capture reagents and detection reagents. For the sandwich 
assay, both reagents should recognize different regions of the target protein if the target 
protein is not a homomultimeric protein. 
2.1.2 B/F separation based on a single aptamer  
Since the sandwich assay requires two molecular recognition elements that can bind to the 
target molecule simultaneously, it is difficult to apply it to the sensing of small molecules 
and proteins that have only one superior molecular recognition element. Therefore, we 
constructed a simple B/F separation system based on single aptamers using a 
conformational change of aptamer. This system consists of two parts: an aptamer and its 
complementary DNA. We previously described two types of single aptamer-based B/F 
separation systems (Abe et al., 2011; Fukasawa et al., 2009; Ogasawara et al., 2009) (Fig. 3). 
The first type of system makes use of the stability feature of aptamers by providing target 
molecules so that the aptamer will bind to them and stabilize its structure (Fig. 3(a)). 
Structures of aptamers are destabilized by repulsion between negative charges. Therefore, 
an aptamer can be easily hybridized with its complementary DNA without target molecule 
binding. On the other hand, since target binding stabilizes the whole structure of the 
aptamer, the aptamer-target complex inhibits hybridization with complementary DNA. We 
designed a complementary DNA named CaDNA that will bind to a part of an aptamer that 
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is amenable to hybridization inhibition upon binding to the aptamer target. We modified the 
aptamer with an avidin-conjugated enzyme and we succeeded in detecting thrombin, IgE 
(Fukasawa et al., 2009), and vascular endothelial growth factor (VEGF) (in preparation) via 
enzymatic activity measurement. 
The second system makes use of the structural changes that aptamers undergo upon 
binding to their target molecules (Fig. 3(b)). We created a "capturable" aptamer by adding a 
sequence to it that gave it a new structure. Capturable aptamers cannot hybridize with 
CaDNA unless their target molecules are present. In this case, the structure of a capturable 
aptamer in the presence of its target molecule changes to a different structure from that 
which was present in the absence of the target molecule. We succeeded in the design of a 
capturable aptamer for thrombin (Abe et al., 2011) and a mouse prion protein (Ogasawara et 
al., 2009). In these studies, although fluorescent labeling was used for detection, enzyme 
labeling enabled a 10-fold lower detection of mouse prion protein than fluorescent labeling 
(unpublished data). 
 
 
Fig. 3. The scheme of a single aptamer-based B/F separation system. (a) In the absence of a 
target molecule, the aptamers are trapped by the immobilized beads containing CaDNA, 
whereas in the presence of the target protein, aptamers that bind to the target are not 
trapped. The target protein can therefore be detected by means of simple B/F separations, 
and by measuring the fluorescence or enzymatic activity of the labeled aptamer in the 
supernatant. (b) The aptamer, which is able to be captured, undergoes a conformational 
change upon binding to the target molecule. This change induces the exposure of a partial 
single-strand that hybridizes with the CaDNA. Otherwise, any unbound capturable aptamer 
does not hybridize with the CaDNA and is removed by the bound/free separation.  
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Of these two types of single aptamer-based B/F separation systems, the first can be easily 
designed, because it does not require any additional sequences, whereas the second system 
requires careful design of the additional sequence of the aptamer with structural prediction. 
However, the benefit of the second system is that it can eliminate many interfering 
compounds. The first system can eliminate enzyme-modified aptamers that do not bind to 
the target molecule, but it is difficult to eliminate interfering compounds because aptamers 
that bind to the target molecule are present in the supernatant. It is therefore necessary to 
select a particular system to suit the needs of each particular target molecule. 
Wei et al. reported a different type of single aptamer based B/F separation system without 
complementary DNA being present (Wei & Ho, 2009). They utilized steric hindrance 
between enzyme-modified antibodies and antigen-modified target-binding aptamers. They 
used fluorescein-modified aptamers and anti-fluorescein horseradish peroxidase (HRP)-
conjugated antibody. The antibody cannot bind to the fluorescein-modified aptamer due to 
steric hindrance without its target molecule. The aptamers change conformation upon 
binding to the target molecule, and then the antibodies can bind to them. Since the aptamers 
were immobilized on the solid support, this sensing system enabled B/F separation to occur 
using an aptamer. 
2.2 Homogeneous sensing 
To measure the target molecules without B/F separation, regulation of signal output is 
required. Jhaveri et al. reported aptamers that changed their structure upon binding to the 
target molecule, which resulted in the regulation of fluorescent signals (Jhaveri et al., 2000). 
If we can introduce enzyme signal amplification into a signaling aptamer, a highly sensitive 
detection can be performed without the need for B/F separation. Reported homogeneous 
detection systems using enzymes are based on two strategies: enzyme activity regulation by 
the target molecule, and DNA amplification accompanied by the target molecule binding to 
aptamers. 
2.2.1 Enzyme activity regulation by the target molecule 
If we can find an enzyme that catalyzes a reaction with a target molecule, we can construct 
an effective sensing system such as the glucose sensor, which is already on the market and is 
being used daily. However, it is difficult to screen an enzyme that reacts with a given target 
molecule. Protein engineering allows us to improve the enzyme substrate specificity, and we 
have reported such examples (Igarashi et al., 2004), but it is still difficult to change the 
substrate specificity dramatically. Then we constructed an enzyme that has a novel subunit 
that can regulate enzymatic activity allosterically based on the aptamer. If the target 
molecule activates enzymatic activity, we can quantify the target molecule via an enzyme 
activity measurement. We named this sensing system the Aptameric Enzyme Subunit (AES) 
(Ikebukuro et al., 2008; Yoshida et al., 2009; Yoshida et al., 2006a, b, 2008).  
An AES consists of two aptamers: an enzyme-inhibiting aptamer and a target molecule-
binding aptamer. The enzyme does not generate signals because the AES inhibits enzymatic 
activity when it is not bound to the target molecules. However, upon binding of the target 
molecules to the AES, the AES changes its conformation, which results in a loss of enzyme 
inhibitory activity. Then we can measure the target molecule concentration via enzyme 
activity measurements without the need for B/F separation. Therefore, an AES acts as an 
enzyme subunit that can regulate its activity via the target molecule binding allosterically.  
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Figure 4 shows a design strategy for an AES. To act as an AES, the binding ability of an 
enzyme-inhibiting moiety against an enzyme should decrease upon binding of the target 
molecule to the target molecule-binding moiety. We used a 31-mer thrombin-binding 
aptamer (TBA) that we optimized as the enzyme-inhibiting aptamer (Fig. 4(a)) (Ikebukuro et 
al. 2005b). The TBA forms a G-quadruplex structure that plays an important role in its 
inhibitory activity. Then we inserted the target molecule-binding moiety into a loop region 
of the G-quadruplex that does not critically affect its binding ability against thrombin. This 
was done by inserting the DNA-binding domain into the TBA (Yoshida et al., 2006b) (Fig. 
4(b)). DNA binding would disrupt the TBA's structure, resulting in an increase of thrombin 
activity. Next, we inserted an adenosine-binding aptamer into the TBA (Yoshida et al., 
2006a) (Fig. 4(c)). We expected that adenosine binding would stabilize the TBA structure 
rather than disrupt it. As expected, we observed a decrease in thrombin activity that was 
dependent on the adenosine concentration. However, it was not obvious whether most 
aptamer stabilization occurred because of the aptamer's structure, or whether there was also 
influence from the TBA's structure upon binding to the target molecule. Then, we designed 
different types of AESs for the purpose of universal molecule sensing (Fig. 4(d)). 
 
 
Fig. 4. Aptameric enzyme subunits using a thrombin-inhibiting aptamer. The target-binding 
aptamer was inserted into a loop of thrombin-inhibiting aptamer that was not a critical 
region for thrombin recognition. a) The structure of 31-mer thrombin-inhibiting aptamer b) 
The AES inhibits thrombin activity without a target DNA. Target DNA hybridization 
induces a destruction of the structure of thrombin-inhibiting aptamer, resulting in an 
increase of thrombin activity. c) There is more inhibition of thrombin activity when the AES 
binds to the target molecule as compared to when there is no target binding. d) The AES 
inhibits thrombin activity without a target molecule. Target molecule binding induces a 
break in hybridization between the target molecule binding aptamer and additional 
complementary DNA, resulting in an increase of thrombin activity. 
We split the TBA into two parts in the same region where a target-binding aptamer was 
inserted. One strand is connected with the target-binding aptamer and another strand is 
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connected with its complementary strand (Fig. 4(d)). Without the target molecule, the target-
binding aptamer moiety hybridizes with its complementary strand, which results in the 
stabilization of the TBA conformation. Then the TBA moiety inhibits thrombin enzymatic 
activity. Target molecule binding disrupts complementary base pairing and results in a 
single-stranded nucleic acid structure, which would destabilize the structure of TBA and 
increase thrombin enzymatic activity. Compared with former AESs, we would be able to 
design a type of AES that is easily split. We succeeded in designing a type of split AES for 
sensing adenosine (Yoshida et al., 2006a), IgE (Yoshida et al., 2008) and insulin (Yoshida et 
al., 2009). 
Chelyapov and Fletcher et al. reported similar sensing systems for AESs (Chelyapov, 2006; 
Fletcher et al., 2010). Chelyapov used an aptamer that inhibited Russell’s viper venom factor 
X activator (RVV-X), and Fletcher et al. used an aptamer that inhibited EcoRI. 
AESs are advantageous because they sense rapidly and easily. Target molecule binding 
transduces enzymatic activity immediately. In addition, an AES does not require the 
modification of an enzyme with an aptamer. Therefore, enzymatic activity can be fully 
utilized. To design AESs for highly sensitive detection, it is most important that the aptamer 
has powerful enzyme inhibitory activity. When we used an aptamer with weak inhibitory 
activity, we had to add a large quantity of it in order to completely inhibit thrombin activity. 
Then most of the aptamer in solution will not bind to enzyme It is difficult to detect low 
concentrations of target molecules because target molecules bind to AESs that do not bind to 
enzyme. Therefore, we should use enzyme-inhibiting aptamers that have a high inhibitory 
activity. 
2.2.2 Real-time PCR or RCA assay 
Fredriksson et al. reported a proximity ligation assay (PLA) (Fredriksson et al., 2002). The PLA 
depends on the simultaneous and proximate recognition of target molecules by pairs of 
affinity probes modified with oligonucleotides. Each modified oligonucleotide can be 
hybridized with connector DNA, resulting in the formation of amplifiable DNA through 
ligation between modified oligonucleotides. Then we can detect target molecules through PCR 
amplification without B/F separation. Fredriksson et al. reported a PLA using an aptamer (Fig. 
5(a)). Although PLA and immuno-PCR require oligonucleotide modification with affinity 
probes, oligonucleotide modification with an antibody is a cumbersome process. On the other 
hand, the aptamer can be easily connected to oligonucleotides by DNA synthesis. Therefore, 
the aptamer is more suitable for immuno-PCR and the PLA than the antibody. 
Di Giusto et al. reported protein detection by rolling cycle amplification (RCA) based on 
proximity extension (Di Giusto, 2005) (Fig. 5(b)). This method used a circular aptamer and 
an aptamer that had a complimentary sequence with a part of a circular aptamer that could 
bind to the target molecule simultaneously. They reported circularization of the aptamer, 
enabling it to stabilize without loss of function. When both aptamers bind to the target 
molecule, complementary DNA hybridizes with a part of the circular DNA, and the rolling 
cycle amplification reaction starts. This method can detect protein, without the need for 
carrying out B/F separation or ligation. 
Although proximity ligation or an extension assay will achieve highly sensitive detection of 
proteins without B/F separation, they require two aptamers that can bind to the target 
molecule simultaneously. There are some reports of protein detection by PCR or RCA that 
employs the conformational change of an aptamer. For PCR, binding to the target molecule 
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should induce a conformational change of the aptamer, and when the aptamer hybridizes to 
its complementary DNA, this will serve as a primer binding site (Yang & Ellington, 2008) 
(Fig. 5(c)). Then we can detect the target molecule by ligation of the aptamer to 
complementary DNA followed by PCR amplification. On the other hand, for RCA, Yang et 
al. designed an aptamer sequence for proximity ligation within the internal aptamer (Yang 
et al., 2007) (Fig. 5(d)). Upon binding of the target molecule, both the 5’ end and 3’ end form 
a stem and join with each other. Then an aptamer is formed by ligation of circular DNA, and 
it is amplified by RCA 
 
 
Fig. 5. Biosensing based on different methods of DNA amplification, accompanied by target 
molecule binding. a) Proximity ligation assay. Two aptamers are ligated after binding to the 
proximate site of target molecules, resulting in the detection of the target through PCR 
amplification. b) Proximity extension assay. An aptamer is circularized and a primer 
sequence that is complementary to a part of the circularized aptamer is added to the other 
aptamer. Proximate binding of both aptamers to the target molecules induce a RCA reaction. 
c) Target molecule binding induces a conformational change in the aptamers. Then, the 
aptamer hybridizes and ligates with probe DNA, resulting in the formation of amplifiable 
DNA, which enables detection of the target through PCR amplification. d) Target molecule 
binding induces a conformational change of the aptamer, resulting in the formation of 
circular DNA by intramolecular ligation. Circular DNA is amplified by RCA. 
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Conformational change of an aptamer is an attractive strategy for biosensing because only 
one aptamer is required. However, to design drastic conformational changes of the aptamer 
would be time-consuming. Although there are many reports of biosensing using 
conformational changes of aptamers, only a few target protein-binding aptamers are used 
because their conformational changes have been thoroughly studied. Wu et al. reported a 
universal aptamer sensing system using RCA (Wu et al., 2010). As previously mentioned, 
the structure of aptamers is stabilized upon binding to a target molecule, resulting in 
inhibition of hybridization with the captured DNA that is a part of the complimentary DNA 
of the aptamer. Wu et al. utilized free capture DNA that was not hybridized with an 
aptamer for formation of circular DNA by ligation, followed by RCA. This sensing system 
does not require careful design of the aptamer's desired conformational change. However, 
the addition of DNA to an aptamer or hybridization with an aptamer before target molecule 
binding results in decreasing binding affinity of the aptamer.  
3. Transduction of binding events into measurable signals by enzymes 
Enzymes can transduce binding events to various measurable signals and amplify them. As 
mentioned above, enzymes are combined with aptamer sensors using various sensing 
schemes. Table 1 shows a list of enzymes combined with aptamer sensors. There are many 
reports that aptamer sensors have been combined with ribozyme or deoxyribozyme (Breaker, 
2002; Kuwabara et al., 2000). (Deoxy)ribozyme is attractive for use as a labelling tool of 
aptamer sensors because it can easily be connected to an aptamer by synthesis, whereas 
enzyme connections often require chemical crosslinking that sometimes causes a decrease in 
enzymatic activity. However, compared with enzymes, there is limited use for 
(deoxy)ribozyme combinations in detection schemes because their activities are much less than 
that of enzymes and they catalyze fewer types of reactions than enzymes. In the following 
subsection, we describe the features of enzymes and detection schemes. We have focused on 
electrochemical biosensors because they can be constructed with low cost and high sensitivity. 
3.1 Oxidoreductase 
Electrochemical sensing applications using aptamers are rapidly increasing (Cho et al., 
2009). Electrochemical sensing systems enable highly sensitive detection of target molecules, 
and these systems can be readily miniaturized at a low cost. Therefore, an electrochemical 
sensing system is suitable for POCT. In fact, the most frequently used biosensor is a glucose 
biosensor, based on electrochemical sensing using glucose dehydrogenase. Since glucose-
sensing systems are well-established and used commercially, they are attractive tools for 
sensing systems of various biomarkers that use aptamers. 
We first reported thrombin sensing using an aptamer conjugated with pyrroloquinoline 
quinone-dependent glucose dehydrogenase (PQQGDH) (Ikebukuro et al., 2004; Ikebukuro 
et al., 2005a). PQQGDH has a high catalytic activity (about 5000 U/mg protein). We used 
glutaraldehyde to crosslink PQQGDH with avidin. Biotin-modified aptamers were labeled 
by PQQGDH through avidin-biotin interaction. Thiol-modified aptamers were immobilized 
on an Au electrode. A sandwich structure was formed on the Au electrode, and we observed 
a current that was dependent on the target molecule concentration via PQQGDH activity 
mediated by 1-methoxy-5-methylphenazinium methyl sulfate with a low detection limit of 
10 nM. However, cross-linking between PQQGDH and avidin resulted in a decrease in 
enzymatic activity. Then we reported the accomplishment of PQQGDH labeling without 
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Name Detection type 
Polymerase Fluorescence 
Phi29 polymerase Fluorescence or electrochemical 
Dehydrogenase Electrochemical 
Peroxidase (HRP) Electrochemical, Chemiluminescence or Fluorescence 
Alkaliphosphatase Electrochemical, Chemiluminescence or Fluorescence 
Nuclease Fluorescence 
Protease Fluorescence or others 
Table 1. Enzyme list for signal amplification in aptamer sensors 
crosslinking using a PQQGDH-binding aptamer (Abe et al., 2010; Osawa et al., 2009). The 
PQQGDH-binding aptamer that we screened was bound to PQQGDH with high affinity 
(Kd: c.a. 40 nM) and specificity, and it did not affect PQQGDH activity. Enzyme labeling of 
target-binding aptamer via noncovalent bonding with enzyme-binding aptamer would help 
us to make a construct for highly sensitive detection. 
3.2 Polymerase 
Since the development of Immuno-PCR in 1992 (Sano et al., 1992), polymerases have been 
used as biosensor signal amplification tools. As contrasted with the cumbersome step of 
antibody modification using oligonucleotides, aptamers are easily applicable to similar 
assays that use immuno-PCR. If the aptamer has sufficient length for primer binding, it can 
be amplified directly (Fischer et al., 2008). Since a PCR reaction can amplify DNA 
exponentially, signal amplification by polymerase enables more highly sensitive detection 
than by ELISA. The limit of detection of a given ELISA is, in general, enhanced 100 to 10000-
fold by the use of PCR as a signal amplification system. The disadvantage of PCR is the 
requirement of a longer reaction time than for other enzyme reactions. Many researchers 
have attempted time reduction of PCR, and they succeeded in a PCR that took 20 minutes 
using Lab-on-a-chip technology (Kim et al., 2009; Kopp et al., 1998). 
Phi29 polymerase has been used to catalyze RCA, and it is also used for signal amplification. 
As contrasted with a typical DNA polymerase, Phi29 polymerase can amplify hundreds of 
copies of a circular DNA template isothermally. This unique amplification was utilized for 
biosensing that could not be performed by a typical DNA polymerase. Isothermal 
amplification has a great advantage for use with biosensing because there is no requirement 
for specific devices. 
The reaction products are ordinarily measured by fluorescence using Sybr® Green I or a 
related molecule that can generate a fluorescent signal upon specific recognition of double-
stranded DNA. In addition, since RCA can isothermally produce a long strand of DNA that is 
connected to the aptamer, the aptamer can be labelled by fluorescence or enzymatic methods 
via DNA probe hybridization. A molecular beacon that can recognize DNA with more 
specificity than Sybr® Green I and can generate a fluorescent signal upon DNA binding will 
enable real-time detection with high specificity. Since RCA products have many probe binding 
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sites, multiple enzyme labelling in a RCA product will enable a 10 to 100-fold signal 
amplification compared with modification of an aptamer with an enzyme (Zhou et al., 2007). 
3.3 Alkaline phosphatase and horseradish peroxidase 
Alkaline phosphatase (ALP) and HRP are mainly used as biosensors when combined with 
an antibody and an aptamer. The most important advantage of these enzymes is that we can 
use commercial avidin conjugates, as well as commercial antibody conjugates. Then we can 
easily apply them to various sensing systems. 
ALP catalyzes the dephosphorylation of various substrates, and is used in various sensing 
systems such as chemiluminescent detection, fluorescence detection and electrochemical 
detection. ALP allows a nonreductive substrate, ascorbic acid 2-phosphate, to be converted 
into reducing agent ascorbic acid at an electrode's surface. Finally, silver ions were reduced 
and deposited on the electrode surface as metallic silver, which was determined by linear 
sweep voltammetry. Zhou et al. combined RCA, to be used for the detection of Platelet-
Derived Growth Factor (PDGF), with ALP by using an electrochemical assay based on silver 
deposition (Zhou et al., 2007). They succeeded in the detection of PDGF with a low detection 
limit of 10 fM. Xiang et al. combined diaphorase with ALP for further signal amplification 
(Xiang et al., 2010). They used p-aminophenylphosphate (p-APP) as a substrate for ALP. 
ALP catalyzes the dephosphorylation of p-APP to p-aminophenol (p-AP), and the p-AP was 
then subjected to an electrochemical oxidation process that caused it to change to p-
quinonimine (p-QI) on the electrode. Diaphorase catalyzes the reduction of p-QI to p-AP, 
coupled with NADH oxidation. Successful thrombin detection occurred with a low 
detection limit of 8.3 fM. The dual amplified detection strategy substantially lowered the 
detection limit by four orders of magnitude compared to common single enzyme-based 
schemes. 
HRP catalyzes reduction of various substrates that is accompanied by hydrogen peroxide 
oxidation. Using a specific mediator such as 3,3',5,5'-tetramethylbenzidine (TMB), HRP has 
been applied to electrochemical detection. TMB was also used for enhancement of surface 
plasmon resonance imaging (SPRI) (Li et al., 2007).  
3.4 Nuclease 
Specific nucleases are used for fluorescence signal amplification using a molecular beacon as 
the substrate. The molecular beacon is a stem-loop type of DNA that is labeled with a 
fluorescent molecule and has a quencher at each termini (Tyagi & Kramer, 1996). Although 
fluorescence is quenched with stem-loop structure formation, fluorescence is observed upon 
binding to the target DNA or the target molecule when structural disruption of the 
molecular beacon is induced. Although most molecular beacons bind to DNA, we can 
design the transduction of any molecule by controlling the binding event of the molecule to 
an aptamer so that specific DNA signals are transmitted, which are then detected by a 
molecular beacon. A simple example is the modification of complementary DNA of a 
molecular beacon with an aptamer in a sandwich assay. Xue et al. used Nb.BbvC I, which is 
one of the nick-end labeling nucleases used for fluorescence signal amplification (Xue et al., 
2010). The molecular beacon recognizes the modified DNA of the aptamer, and then 
Nb.BbvC I cleaves the hybrid of the molecular beacon with the aptamer. Since Nb.BbvC I 
introduces a nick to the strands of the molecular beacon, the molecular beacon then 
dissociates from the aptamer. The released target strand could then hybridize to another 
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molecular beacon and initiate a second cycle of cleavage. Each DNA strand modified by an 
aptamer has the capability to go through many such cycles.  
Fletcher et al. also used a molecular beacon inserted into the EcoRI recognition sequence 
(Fletcher et al., 2010). They used EcoRI to inhibit the aptamer and DNA, which consisted of 
target-binding of the DNA and the complementary DNA of EcoRI that would inhibit the 
aptamer. The binding of the target DNA induces hybridization of the complementary DNA 
to the EcoRI-inhibiting aptamer, resulting in an increase of fluorescence via cleaving of the 
molecular beacon by active EcoRI.  
3.4 Protease 
Since TBA is well characterized, some researchers, including ourselves, have used thrombin 
as a detection enzyme, utilizing ability of TBA inhibiting thrombin activity (Pavlov et al., 
2005; Yoshida et al., 2006a). Protease activity was measured using a synthetic peptide 
labeled with a fluorescent molecule as the substrate. In the case of a protease such as 
thrombin and RVV-X factor X activator, we can measure protease activity via observation of 
the coagulation that results from enzymatic activity. Chelyapov constructed a biosensor that 
can evaluate RVV-X activity with the naked eye, using microspheres for signal amplification 
(Chelyapov, 2006). Chelyapov succeeded in the detection of VEGF with a low detection limit 
of 5 fmol. Despite semi-quantitative or qualitative assays, visible detection is suitable for 
POCT because it does not require specific devices.  
4. Conclusion 
Many aptamer sensors have been reported for the past two decades. However, antibodies 
are still commonly used for diagnostics because unlike aptamers, many kinds of antibodies 
can be utilized. Although different kinds of aptamers have been increasing every year, it is 
difficult to replace aptamer sensors with existing antibody-based devices. Therefore, we 
should not use aptamers as alternatives for antibodies, but instead, we should utilize their 
unique properties accompanied with their molecular structure for constructing sensors. 
There is a strong need for aptamer sensors to be developed for theranostics and POCT, since 
there is substantial growth in the demand for biomarkers that will be used in drug 
development and in vitro diagnosis. 
As mentioned above, certain properties of aptamers enable us to construct biosensors that 
are suitable for POCT. They can easily measure target molecules with high sensitivity and 
rapidity. Aptamers enable us to construct homogeneous biosensors that can use any 
enzyme. Most homogeneous sensing systems that use antibodies require specific devices or 
are based on the aggregation of beads, resulting in a sandwich formation. However, we can 
construct various homogeneous biosensors, including those based on electrochemical 
systems, utilizing various enzyme activities. The AES is a most ideal sensing system because 
it can amplify signals without any cumbersome processes, although optimization would 
require rigorous control of the structural change of the aptamer in order to enable highly 
sensitive detection. If we can obtain the aptamer that inhibits glucose dehydrogenase, we 
would be able to construct attractive biosensors. 
One of advantages of aptamers for theranostics is that they can measure target molecules by 
binding to them. Homogeneous detection with capturable aptamers enable the detection of 
a target molecule using a single aptamer. We can detect any molecules, from cells to small 
molecules, based on the same sensing strategies, and we do not have to select and optimize 
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two affinity probes. As a short-term goal, we should develop biosensors for novel 
biomarkers, since aptamers would be excellent candidates for affinity probes that facilitate 
the construction of a biosensing system for any biomarker. 
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